HomeInsightsStock Comparison

Ipca Laboratories Ltd vs Syncom Formulations India Ltd Stock Comparison

Ipca Laboratories Ltd vs Syncom Formulations India Ltd Stock Comparison

Last Updated on: Jun 10, 2025

Key Highlights

  • The Latest Trading Price of Ipca Laboratories Ltd is ₹ 1359 as of 10 Jun 10:09.
  • The P/E Ratio of Ipca Laboratories Ltd changed from 30.5 on March 2022 to 21.2 on March 2021 . This represents a CAGR of -7.02% over 5 yearsThe P/E Ratio of Syncom Formulations (India) Ltd changed from 46.2 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Ipca Laboratories Ltd changed from ₹ 26921 crore on March 2022 to ₹ 24137 crore on March 2021 . This represents a CAGR of -2.16% over 5 yearsThe Market Cap of Syncom Formulations (India) Ltd changed from ₹ 916.79 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 years.
  • The revenue of Ipca Laboratories Ltd for the Mar '25 is ₹ 2272 crore as compare to the Dec '24 revenue of ₹ 2265 crore. This represent the growth of 0.31% The revenue of Syncom Formulations (India) Ltd for the Mar '25 is ₹ 155.83 crore as compare to the Dec '24 revenue of ₹ 131.57 crore. This represent the growth of 18.44%.
  • The ebitda of Ipca Laboratories Ltd for the Mar '25 is ₹ 249.63 crore as compare to the Dec '24 ebitda of ₹ 483.19 crore. This represent the decline of -48.34% The ebitda of Syncom Formulations (India) Ltd for the Mar '25 is ₹ 24.7 crore as compare to the Dec '24 ebitda of ₹ 18.77 crore. This represent the growth of 31.59%.
  • The net profit of Ipca Laboratories Ltd changed from ₹ 166.21 crore to ₹ 65.78 crore over 8 quarters. This represents a CAGR of -37.09% The net profit of Syncom Formulations (India) Ltd changed from ₹ 4.4 crore to ₹ 17.69 crore over 8 quarters. This represents a CAGR of 100.51% .
  • The Dividend Payout of Ipca Laboratories Ltd changed from 9.68 % on March 2020 to 19.13 % on March 2024 . This represents a CAGR of 14.60% over 5 yearsThe Dividend Payout of Syncom Formulations (India) Ltd changed from 13.07 % on March 2022 to 0 % on March 2024 . This represents a CAGR of -100.00% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ipca Laboratories Ltd

  • Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
  • The products of the Company are now sold in over 100 countries across the globe.
  • The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market. Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries.

About Syncom Formulations (India) Ltd

  • Incorporated as a private limited company in 1988, Syncom Formulations (India) Limited was converted into a public limited company in Jun.'92.
  • The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.
  • Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
  • Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations.

Ipca Laboratories Ltd News Hub

News

Board of Ipca Laboratories recommends final dividend

Ipca Laboratories announced that the Board of Directors of the Company at its meeting held...

Read more

29 May 2025 14:29

News

Ipca Laboratories to announce Quarterly Result

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 29 May 2...

Read more

15 May 2025 15:38

News

Ipca Laboratories now holds 100% stake in Unichem Laboratories, Ireland

Ipca Laboratories announced that 100% of the paid-up equity share capital of Unichem Labor...

Read more

02 May 2025 11:27

News

Ipca Laboratories appoints President - Human Resources

Ipca Laboratories has appointed Saidutta Nanda as President - Human Resources of the compa...

Read more

03 Mar 2025 16:06

News

Ipca Laboratories Ltd down for fifth straight session

Ipca Laboratories Ltd is down for a fifth straight session today. The stock is quoting at ...

Read more

28 Feb 2025 13:35

News

Ipca Labs spurts after Q3 PAT soars to Rs 267 cr

Revenue from operations jumped 10.34% YoY to Rs 1,662.68 crore in the quarter ended 31st D...

Read more

13 Feb 2025 15:03

Syncom Formulations (India) Ltd News Hub

News

Syncom Formulations (India) schedules board meeting

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

14 May 2025 14:06

News

Syncom Formulations (India) to convene board meeting

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

05 Nov 2024 14:12

News

Syncom Formulations (India) schedules AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 2024 17:48

News

Syncom Formulations (India) to hold AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 2024 10:30

News

Syncom Formulations gains after Q1 PAT rises over 73% YoY

Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Total e...

Read more

13 Aug 2024 13:37

News

Syncom Formulations (India) announces board meeting date

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

06 Aug 2024 11:37

SWOT Analysis Of Ipca Laboratories Ltd

Strength

2

S

Weakness

4

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Syncom Formulations (India) Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Ipca Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Syncom Formulations (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ipca Laboratories Ltd and Syncom Formulations (India) Ltd

Which company has a larger market capitalization, Ipca Laboratories Ltd or Syncom Formulations (India) Ltd?

Market cap of Ipca Laboratories Ltd is 34,723 Cr while Market cap of Syncom Formulations (India) Ltd is 2,014 Cr

What are the key factors driving the stock performance of Ipca Laboratories Ltd and Syncom Formulations (India) Ltd?

The stock performance of Ipca Laboratories Ltd and Syncom Formulations (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ipca Laboratories Ltd and Syncom Formulations (India) Ltd?

As of June 10, 2025, the Ipca Laboratories Ltd stock price is INR ₹1368.65. On the other hand, Syncom Formulations (India) Ltd stock price is INR ₹21.43.

How do dividend payouts of Ipca Laboratories Ltd and Syncom Formulations (India) Ltd compare?

To compare the dividend payouts of Ipca Laboratories Ltd and Syncom Formulations (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions